UBS downgraded Marathon Oil to Neutral from Buy with a price target of $28, down from $34. UBS sees the E.G. re-contracting catalyst as already priced into the forward outlook, but continues to view Marathon as a leader in shareholder returns, the analyst tells investors in a research note. UBS also believes additional volatility that TTF exposure brings will instead keep the valuation gap vs. peers wide.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MRO:
- Marathon Oil just downgraded at Morgan Stanley, here’s why
- The top E&P and natural gas stocks to own in 2024, according to JPMorgan
- Marathon Oil price target lowered to $33 from $36 at JPMorgan
- Marathon Oil price target lowered to $30 from $32.50 at Citi
- Marathon Oil put volume heavy and directionally bearish